Pending Changes. There is no pending or, to the Company’s Knowledge, threatened change in any law, rule, regulation or order applicable to the Company’s business, operations, properties, assets, products and services which could reasonably be expected to result in a Material Adverse Change. To the Company’s Knowledge, there has been no discovery or change in the development, design, manufacture or marketing of any product or service or proposed product or service of the Company, or any product or service that is or may be competitive with any such product or service or of any new or improved materials, products, services or processes useful in the business or the proposed business of the Company, to which an informed investor in the Company would attach importance in such investor’s decision to make an investment in the Company.
Appears in 2 contracts
Sources: Stock Purchase Agreement, Series B Preferred Stock Purchase Agreement (Heat Biologics, Inc.)